Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.


Journal

Clinical radiology
ISSN: 1365-229X
Titre abrégé: Clin Radiol
Pays: England
ID NLM: 1306016

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 05 2020
accepted: 24 08 2020
pubmed: 11 10 2020
medline: 4 6 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

To determine whether machine learning-based radiomic feature analysis of baseline integrated 2-[ Patients with larynx and hypopharynx SCC treated with definitive (chemo)radiotherapy at a specialist cancer centre undergoing pre-treatment PET-CT between 2008 and 2017 were included. Tumour segmentation and radiomic analysis was performed using LIFEx software (University of Paris-Saclay, France). Data were assigned into training (80%) and validation (20%) cohorts adhering to TRIPOD guidelines. A random forest classifier was created for four predictive models using features determined by recursive feature elimination: (A) PET, (B) CT, (C) clinical, and (D) combined PET-CT parameters. Model performance was assessed using area under the curve (AUC) receiver operating characteristic (ROC) analysis. Seventy-two patients (40 hypopharynx 32 larynx tumours) were included, mean age 61 (range 41-77) years, 50 (69%) were men. Forty-five (62.5%) had chemoradiotherapy, 27 (37.5%) had radiotherapy alone. Median follow-up 26 months (range 12-105 months). Twenty-seven (37.5%) patients progressed within 12 months. ROC AUC for models A, B, C, and D were 0.91, 0.94, 0.88, and 0.93 in training and 0.82, 0.72, 0.70, and 0.94 in validation cohorts. Parameters in model D were metabolic tumour volume (MTV), maximum CT value, minimum standardized uptake value (SUVmin), grey-level zone length matrix (GLZLM) small-zone low grey-level emphasis (SZLGE) and histogram kurtosis. FDG PET-CT derived radiomic features are potential predictors of early disease progression in patients with locally advanced larynx and hypopharynx SCC.

Identifiants

pubmed: 33036778
pii: S0009-9260(20)30386-X
doi: 10.1016/j.crad.2020.08.030
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78.e9-78.e17

Informations de copyright

Copyright © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Auteurs

J Zhong (J)

Department of Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Electronic address: jim.zhong@nhs.net.

R Frood (R)

Department of Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

P Brown (P)

Department of Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

H Nelstrop (H)

Department of Medical Physics, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

R Prestwich (R)

Department of Clinical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

G McDermott (G)

Department of Medical Physics, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

S Currie (S)

Department of Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Radiotherapy Research Group, Leeds Institute of Medical Research, Faculty of Medicine & Health, University of Leeds, Leeds, UK.

S Vaidyanathan (S)

Department of Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

A F Scarsbrook (AF)

Department of Clinical Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Radiotherapy Research Group, Leeds Institute of Medical Research, Faculty of Medicine & Health, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH